ConductScience.org, home

Paper38643239

A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease.

Li HY and 9 others. Commun Chem, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease. Papers, record 38643239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38643239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease.
PubMed
Journal
Commun Chem
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.56, provisional
iCite
Revised in PubMed
2024-04-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li HYHuang-Yi
2Chen WAWei-Anhttps://orcid.org/0000-0001-9087-5414
3Lin HYHung-Yi
4Tsai CWChi-Wei
5Chiu YTYu-Ting
6Yun WYWen-Yi
7Lee NCNi-Chung
8Chien YHYin-Hsiuhttps://orcid.org/0000-0001-8802-5728
9Hwu WLWuh-Liang
10Cheng WCWei-Chiehhttps://orcid.org/0000-0002-9319-3010

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18611585Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors.Biochemistry1996https://conductscience.org/library/papers/8611585PubMed
218328804Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase.Biochem Biophys Res Commun2008https://conductscience.org/library/papers/18328804PubMed
314533157Rapid diversity-oriented synthesis in microtiter plates for in situ screening: discovery of potent and selective alpha-fucosidase inhibitors.Angew Chem Int Ed Engl2003https://conductscience.org/library/papers/14533157PubMed
422308055Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?Angew Chem Int Ed Engl2012https://conductscience.org/library/papers/22308055PubMed
516945909The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16945909PubMed
627063389Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201C.Carbohydr Res2016https://conductscience.org/library/papers/27063389PubMed
716231389Rational design and synthesis of highly potent beta-glucocerebrosidase inhibitors.Angew Chem Int Ed Engl2005https://conductscience.org/library/papers/16231389PubMed
816397876Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.Chembiochem2006https://conductscience.org/library/papers/16397876PubMed
929719681Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones.Chem Sci2018https://conductscience.org/library/papers/29719681PubMed
1023943613From natural product-inspired pyrrolidine scaffolds to the development of new human Golgi α-mannosidase II inhibitors.Chem Asian J2013https://conductscience.org/library/papers/23943613PubMed
1121751327Synthesis, kinetic evaluation and cell-based analysis of C-alkylated isofagomines as chaperones of β-glucocerebrosidase.Chembiochem2011https://conductscience.org/library/papers/21751327PubMed
1232899288Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and C-5a-Substituted Derivatives of 4-epi-Isofagomine.Molecules2020https://conductscience.org/library/papers/32899288PubMed
1328265599Screening methods for identifying pharmacological chaperones.Mol Biosyst2017https://conductscience.org/library/papers/28265599PubMed
1425688781Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial.JAMA2015https://conductscience.org/library/papers/25688781PubMed
1535733906Harnessing natural-product-inspired combinatorial chemistry and computation-guided synthesis to develop N-glycan modulators as anticancer agents.Chem Sci2022https://conductscience.org/library/papers/35733906PubMed
1635535638Synthesis of Nitrone-derived Pyrrolidine Scaffolds and Their Combinatorial Libraries to Develop Selective α-l-Rhamnosidase Inhibitors.Chem Asian J2022https://conductscience.org/library/papers/35535638PubMed
1729289886Synthesis of (3S,4S,5S)-trihydroxylpiperidine derivatives as enzyme stabilizers to improve therapeutic enzyme activity in Fabry patient cell lines.Eur J Med Chem2018https://conductscience.org/library/papers/29289886PubMed
189157194Fagomine isomers and glycosides from Xanthocercis zambesiaca.J Nat Prod1997https://conductscience.org/library/papers/9157194PubMed
1927043200Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases.Chem Commun (Camb)2016https://conductscience.org/library/papers/27043200PubMed
2017187079Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.Nat Chem Biol2007https://conductscience.org/library/papers/17187079PubMed

See all 44 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42915455Prism[5]arene Iminosugar Bioconjugates Are Potent Multivalent Inhibitors and Mutation Specific Pharmacological Chaperones of Glucocerebrosidase (GCase) Activity.Bioconjug Chem2026https://conductscience.org/library/papers/42915455PubMed
42889562A pH-Dependent Curcumin-Iminosugar Hybrid Promotes GCase Enhancement and Reactive Oxygen Species Reduction.ACS Omega2026https://conductscience.org/library/papers/42889562PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C5AR1728PubTator's text mininghttps://conductscience.org/library/genes/728NCBI Gene
GBA12629PubTator's text mininghttps://conductscience.org/library/genes/2629NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38643239

GET https://conductscience.org/api/papers/v1/38643239/references?page=2